FDA reform national uniformity wording may "eliminate" liability suits -- Public Citizen.
This article was originally published in The Tan Sheet
FDA REFORM NATIONAL UNIFORMITY PROVISIONS COULD "ELIMINATE" PRODUCT LIABILITY lawsuits, Public Citizen asserted at a June 3 press conference in Washington, D.C. Public Citizen President Joan Claybrook took issue with a provision in the legislation establishing national uniformity for OTC drugs. The provision is included in both the House and Senate versions of FDA reform legislation ("The Tan Sheet" April 1, p. 1).
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC